ORAXIN

This brand name is authorized in Nigeria.

Active ingredients

The drug ORAXIN contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Cyproheptadine UNII `NJ82J0F8QC` - CYPROHEPTADINE HYDROCHLORIDE
	Cyproheptadine is a first generation antihistamine which also has anticholinergic and antiserotonergic activities that is used to treat allergic conditions including seasonal rhinitis, conjunctivitis, dermatitits and urticaria.
	Read more about Cyproheptadine
`2`	Peptone
`3`	Lysine UNII `JNJ23Q2COM` - LYSINE HYDROCHLORIDE
	Read more about Lysine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-1647	Syrup	Oraxin Syrup SYRUP 2 mg/5 mL; 25 mg/5 mL; 150 mg/5 mL	Each 5 mL syrup contains: Cyproheptadine Hydrochloride BP 2 mg, Peptone 25 mg, Lysine Hydrochloride USP 150 mg	26/08/2021

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1647

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.